US to Pull $500m from mRNA Vaccine Research Citing “More Risk Than Benefit”
Source link
US to Pull $500m from mRNA Vaccine Research Citing “More Risk Than Benefit”
Source link
When COVID-19 booster vaccines are in short supply, prioritizing the elderly over other age groups for booster vaccination results in the lowest loss of life, reports Robin Thompson at the
Jan, from Kent, was one of the first people in the world to take part in the trials of semaglutide. It is sold as Wegovy for weight-loss and as Ozempic
Parents across the U.S. should soon be able to determine how much lead, arsenic, cadmium and mercury are in the food they feed their babies, thanks to a California law,